Skip to content

Assessment of Stress Levels in Consumers Using Ovulation Tests in Order to Conceive

Assessment of Stress Levels in Consumers Using Ovulation Tests in Order to Conceive

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01084304
Enrollment
150
Registered
2010-03-10
Start date
2010-02-28
Completion date
2011-06-30
Last updated
2017-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Keywords

Pregnancy, Ovulation tests, stress, Wishing to become pregnant

Brief summary

Approximately 150 female volunteers wishing to become pregnant will be recruited via web recruitment from around the UK and randomised 1:1 to receive Clearblue Digital ovulation tests (active arm) or no aid to conception (control arm) for 2 full menstrual cycles. All volunteers will complete study questionnaires and provide a urine sample at designated time points though out the menstrual cycle. A sub-arm to this study, applied the same protocol to women in an infertility treatment setting; Royal Hallamshire Hospital, Sheffield. Additional exclusion criteria were applied to this cohort; had regular menstrual cycles between 25 and 35 days, and who did not have a diagnosis of bilateral or unilateral tubal blockage, documented anovulation or severe male-factor infertility (with \<5 million motile sperm per ejaculate). For this arm, the protocol was reviewed by Sheffield Research Ethics Committee 09/H1308/134.

Interventions

None listed

Sponsors

SPD Development Company Limited
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Provide written informed consent to participate in the study and agree to comply with study procedures. * Has menstrual bleeds. * Seeking to become pregnant. * Living in UK

Exclusion criteria

* Used hormonal contraception within the last 3 months. * Currently undergoing fertility treatment or investigation. * Diagnosed as infertile following investigations. * Drug or alcohol dependency. * history of depression, anxiety or panic attacks

Design outcomes

Primary

MeasureTime frameDescription
Cortisol MeasurementTwice monthlyMeasurement of Urinary Cortisol throughout menstrual cycle

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026